-
Pravastatin Sodium in Hepatocyte Assay Design
2026-09-15
Pravastatin sodium is a mechanistically defined HMG-CoA reductase inhibitor for connecting cholesterol biology with hepatocyte exposure and transporter-aware assay interpretation. This guide integrates product data with a recent açaí hepatocyte study to improve experimental controls, endpoint selection, and translational reasoning.
-
Auranofin at the Redox–Mechanics Interface
2026-09-15
A thought-leadership perspective on using Auranofin as a thioredoxin reductase inhibitor in cancer research, with a strategic framework linking redox disruption, apoptosis, radiosensitization, and cytoskeleton-dependent autophagy.
-
FAISL Stabilizes FAK by Blocking Calpain 2 in TNBC
2026-09-14
The reference study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by preventing calpain 2-mediated proteolysis. Its combination of transcriptomic analysis, RNA–protein interaction mapping, functional assays, and nanoparticle-mediated silencing connects post-translational FAK control with triple-negative breast cancer progression and metastasis.
-
Mitoxantrone Assay Design Guide
2026-09-14
A scenario-based guide to using Mitoxantrone (SKU BA2039) in viability, proliferation, apoptosis, and ABCG2-resistance assays. It covers solvent compatibility, dose–response design, interpretation, and practical product-selection criteria for more comparable laboratory data.
-
Prostaglandin E2 (PGE2): Mechanism & Research Use
2026-09-13
Prostaglandin E2 (PGE2) is an endogenous lipid-derived autacoid that activates four EP GPCR subtypes with distinct binding profiles. This guide connects receptor pharmacology, inflammation research, gastrointestinal mucosal protection, and practical handling of SKU B7005 while separating product specifications from indirect cardiovascular evidence.
-
GW 6471: From PPARα Signal to Causal Insight
2026-09-12
GW 6471 is a PPARα antagonist that helps translational researchers move from pathway association to causal testing. This thought-leadership guide connects PFHxS-induced zebrafish hepatotoxicity with experimental design for cellular metabolism research, lipid homeostasis studies, and PPARα-related disease modeling.
-
Acetylcysteine for Redox-Aware TNBC Assays
2026-09-12
Acetylcysteine can function as a mechanistic redox probe in triple-negative breast cancer nanotherapy assays, not merely as an antioxidant supplement. This guide explains how N-acetyl-L-cysteine can help separate photothermal injury, oxidative signaling, and immune-remodeling effects while preserving rigorous experimental interpretation.
-
Z-IETD-FMK Workflows for Caspase-8 Mapping
2026-09-11
Z-IETD-FMK enables targeted testing of caspase-8 dependence in activated T cells, death-receptor assays, and TRAIL responses. This workflow-focused guide shows how to separate upstream caspase-8 signaling from mitochondrial apoptosis, necroptosis, and nonspecific proliferation effects.
-
CSBTA Pharmacokinetics in MASH: Study Insights
2026-09-11
The reference study integrates plasma pharmacokinetics, tissue distribution, intracellular accumulation, and transporter or enzyme assays to explain why Corydalis saxicola Bunting total alkaloids behave differently in healthy and MASH-model mice. Its findings show that disease state and repeated dosing can increase exposure to key alkaloids, offering a mechanistic basis for more cautious dose-regimen design in MASLD/MASH research.
-
3-Methyladenine Workflow for Autophagy Research
2026-09-10
Use 3-Methyladenine as a mechanistic perturbation tool to test whether autophagy contributes to neuronal protection, axonal sprouting, tumor-cell survival, or migration phenotypes. This workflow combines time-resolved dosing, pathway controls, and orthogonal readouts so 3-MA results are not overinterpreted as proof of autophagy inhibition alone.
-
HLA-G+ EVTs in Maternal-Fetal Interaction Research
2026-09-10
Hamilton et al. present a practical protocol for isolating, culturing, and functionally testing HLA-G+ extravillous trophoblasts from distinct placental interfaces. The workflow connects primary fetal trophoblast biology with maternal leukocyte co-culture, enabling more reproducible studies of immune regulation at the maternal-fetal boundary.
-
EPI-001: Androgen Receptor N-Terminal Domain Inhibition
2026-09-09
EPI-001 is an androgen receptor N-terminal domain inhibitor designed to probe both ligand-dependent and ligand-independent AR signaling. This guide translates its mechanism into reproducible prostate cancer, CRPC, and exploratory AR/ARv7 assay workflows, with practical formulation and troubleshooting advice.
-
Pentoxifylline: Reading Cytokine Assays in Context
2026-09-09
Pentoxifylline is a phosphodiesterase inhibitor whose value in inflammation research depends on context, timing, cell type, and endpoint selection. This article interprets disease-informed cytokine evidence and translates it into better assay decisions across immune, infectious-disease, and translational models.
-
miRNA–mRNA Modules Drive Juvenile Hormone Biosynthesis
2026-09-08
Li and colleagues show that coordinated miRNA–mRNA regulation in the locust corpora allata supports the high juvenile hormone output required for vitellogenesis and egg production. The study combines transcriptomics, expression validation, reporter assays, and agomiR perturbation to connect post-transcriptional control with vitellogenin expression and ovarian development.
-
Cy3 RNA Labeling Kit: Practical T7 Workflow
2026-09-08
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus supports in vitro synthesis of randomly Cy3-modified RNA probes for fluorescence-based RNA detection, including in situ hybridization and Northern blot workflows. It is intended for research use only and should not be used for diagnostic, therapeutic, or clinical applications.